The event held by TUM Venture Labs provided Trials24 with the opportunity to share its unique journey of solo bootstrapping within patient recruitment for clinical trials.
“As the sole founder, navigating the complexities of Trials24’s development without external funding has been both challenging and rewarding,” — said Dr. Tobias Kruse, founder and CEO of Trials24.
Trials24 engaged the audience with insights garnered from first-hand experience, emphasizing the following key points:
If you have any questions about this event or need to shorten your patient recruitment timeline, please contact us.
Image from: LinkedIn Post by TUM Venture Labs
Trials24 GmbH
Trials24 accelerates patient recruitment to support biopharmaceutical companies and CROs complete their clinical trials on time, bringing innovative drugs to patients faster.
© Copyright | Trials24 GmbH